ask="14.71"
ask_size="100"
average_daily_volume="24333"
bid="13.00"
bid_size="5000"
book_value="6.83"
change="-0.56"
change_from_200_day_moving_average="-0.55"
change_from_50_day_moving_average="-1.21"
change_from_52_week_high="-3.58"
change_From_52_week_low="4.56"
change_in_percent="-3.80%"
close="14.19"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.99"
ebitda="-31.36M"
eps_estimate_current_year="-2.17"
eps_estimate_next_quarter="-0.74"
eps_estimate_next_year="-2.96"
ex_dividend_date="N/A"
float_shares="7120000"
high="15.07"
high_52_weeks="17.77"
last_trade_date="1/9/2017"
last_trade_price="14.19"
last_trade_size="1372"
last_trade_time="4:00pm"
low="14.11"
low_52_weeks="9.63"
market_capitalization="296.73M"
moving_average_200_day="14.74"
moving_average_50_day="15.40"
name="Corvus Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="24.75"
open="14.62"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-3.74%"
percent_change_from_50_day_moving_average="-7.86%"
percent_change_from_52_week_high="-20.14%"
percent_change_from_52_week_low="+47.35%"
previous_close="14.75"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.16"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="20911000"
short_ratio="12.26"
stock_exchange="NGM"
symbol="CRVS"
volume="18165"
weeks_range_52="9.63 - 17.77"
